BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19928084)

  • 1. Patient-specific quality assurance method for VMAT treatment delivery.
    Schreibmann E; Dhabaan A; Elder E; Fox T
    Med Phys; 2009 Oct; 36(10):4530-5. PubMed ID: 19928084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose reconstruction for volumetric modulated arc therapy (VMAT) using cone-beam CT and dynamic log files.
    Qian J; Lee L; Liu W; Chu K; Mok E; Luxton G; Le QT; Xing L
    Phys Med Biol; 2010 Jul; 55(13):3597-610. PubMed ID: 20526034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A real time dose monitoring and dose reconstruction tool for patient specific VMAT QA and delivery.
    Tyagi N; Yang K; Gersten D; Yan D
    Med Phys; 2012 Dec; 39(12):7194-204. PubMed ID: 23231270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
    Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
    J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric-modulated arc therapy: effective and efficient end-to-end patient-specific quality assurance.
    O'Daniel J; Das S; Wu QJ; Yin FF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1567-74. PubMed ID: 21470797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of phantom-based and log file patient-specific QA with complexity scores for VMAT.
    Agnew CE; Irvine DM; McGarry CK
    J Appl Clin Med Phys; 2014 Nov; 15(6):4994. PubMed ID: 25493524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RapidArc patient specific mechanical delivery accuracy under extreme mechanical limits using linac log files.
    Wijesooriya K; Aliotta E; Benedict S; Read P; Rich T; Larner J
    Med Phys; 2012 Apr; 39(4):1846-53. PubMed ID: 22482606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.
    Park SY; Kim IH; Ye SJ; Carlson J; Park JM
    Med Phys; 2014 Nov; 41(11):111718. PubMed ID: 25370632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis for patient-specific quality assurance of volumetric-modulated arc therapy plans.
    Li G; Wu K; Peng G; Zhang Y; Bai S
    Med Dosim; 2014; 39(4):309-13. PubMed ID: 24958705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy.
    Hirashima H; Nakamura M; Miyabe Y; Uto M; Nakamura K; Mizowaki T
    Radiat Oncol; 2018 Feb; 13(1):27. PubMed ID: 29444693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of phantom-less IMRT delivery verification using Varian DynaLog files and R/V output.
    Agnew CE; King RB; Hounsell AR; McGarry CK
    Phys Med Biol; 2012 Nov; 57(21):6761-77. PubMed ID: 23032423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for routine quality assurance of volumetric-modulated arc therapy.
    Wang Q; Dai J; Zhang K
    Med Phys; 2013 Oct; 40(10):101712. PubMed ID: 24089902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commissioning and quality assurance for VMAT delivery systems: An efficient time-resolved system using real-time EPID imaging.
    Zwan BJ; Barnes MP; Hindmarsh J; Lim SB; Lovelock DM; Fuangrod T; O'Connor DJ; Keall PJ; Greer PB
    Med Phys; 2017 Aug; 44(8):3909-3922. PubMed ID: 28564208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-resolved dose reconstruction by motion encoding of volumetric modulated arc therapy fields delivered with and without dynamic multi-leaf collimator tracking.
    Ravkilde T; Keall PJ; Grau C; Høyer M; Poulsen PR
    Acta Oncol; 2013 Oct; 52(7):1497-503. PubMed ID: 23984811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological consequences of MLC calibration errors in IMRT delivery and QA.
    Moiseenko V; Lapointe V; James K; Yin L; Liu M; Pawlicki T
    Med Phys; 2012 Apr; 39(4):1917-24. PubMed ID: 22482613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commissioning and quality assurance for intensity modulated radiotherapy with dynamic multileaf collimator: experience of the Pontificia Universidad Católica de Chile.
    Venencia CD; Besa P
    J Appl Clin Med Phys; 2004; 5(3):37-54. PubMed ID: 15753938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomy-based, patient-specific VMAT QA using EPID or MLC log files.
    Defoor DL; Vazquez-Quino LA; Mavroidis P; Papanikolaou N; Stathakis S
    J Appl Clin Med Phys; 2015 May; 16(3):5283. PubMed ID: 26103490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Log File and Calibration Errors-based Patient-specific Quality Assurance (QA) for Volumetric Modulated Arc Therapy (VMAT).
    Ma Y; Mou X; Beeraka NM; Guo Y; Liu J; Dai J; Fan R
    Curr Pharm Des; 2023; 29(34):2738-2751. PubMed ID: 37916622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate.
    Burman C; Chui CS; Kutcher G; Leibel S; Zelefsky M; LoSasso T; Spirou S; Wu Q; Yang J; Stein J; Mohan R; Fuks Z; Ling CC
    Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):863-73. PubMed ID: 9369136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.